🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and efficacy of a lo...
Status
Completed
Location
North Central Neurology Associates, PC
Start Date
2011-03
Trial ID
NCT01328379
Treatments Being Tested
The primary objective of the study is to evaluate the long-term safety and ...
Status
Completed
Location
Foothills Medical Center
Start Date
2010-12
Trial ID
NCT01235221
Treatments Being Tested
The purpose of this study is to assess whether 4-AP (Dalfampridine-ER, Ampy...
Status
Completed
Location
Columbia University Medical Center
Start Date
2012-06-01
Trial ID
NCT01645787
Treatments Being Tested
The objectives of this study in Multiple Sclerosis (MS) participants treate...
Status
Completed
Location
Research Site
Start Date
2012-08
Trial ID
NCT01597297
Treatments Being Tested
The only approved treatment for impaired ambulation in MS is Dalfampridine ...
Status
Unknown
Location
Ain Shams Univeristy
Start Date
2021-06-01
Trial ID
NCT05730738
Treatments Being Tested
A double-blind, placebo-controlled, crossover study in subjects with cerebr...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-12
Trial ID
NCT01468350
Treatments Being Tested
This is an extension study to evaluate the long-term safety, tolerability, ...
Status
Terminated
Location
Acorda Site #117
Start Date
2015-04
Trial ID
NCT02422940
Treatments Being Tested